Comparison between the role of intraoperative mitomycin C and doxorubicin in preventing the recurrence of primary pterygium

Ophthalmic Research

Volumn 37, Issue 1, 2005, Pages 1-6

  Sodhi, Punita Kumari ^a,e   Verma, Lalit ^b   Pandey, Ravindra M ^c   Ratan, Simmi ^d  

^a SAFDARJUNG HOSPITAL   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^d POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^e Safdarjung Development Area   (India)

Author keywords

Primary pterygium; Pterygium and doxorubicin; Pterygium and mitomycin C

Indexed keywords

ANTIMITOTIC AGENT; DOXORUBICIN; MITOMYCIN C;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONJUNCTIVA DISEASE; CONJUNCTIVAL HEMORRHAGE; CONJUNCTIVAL HYPEREMIA; CONJUNCTIVAL NECROSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA; CORNEA INJURY; DEMOGRAPHY; DRUG EFFICACY; DRUG SAFETY; EPISCLERITIS; EYE IRRITATION; EYE PAIN; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR FOREIGN BODY; INTRAOCULAR PRESSURE ABNORMALITY; LACRIMATION; MAJOR CLINICAL STUDY; MALE; OCULAR PRURITUS; PEROPERATIVE CARE; PHOTOPHOBIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PTERYGIUM; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SURGICAL PATIENT; SURGICAL WOUND; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; FEMALE; HUMANS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; MITOMYCIN; OPHTHALMIC SOLUTIONS; PTERYGIUM; RECURRENCE; TREATMENT OUTCOME;

EID: 18644369038     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000082763     Document Type: Article

References (28)

1. Manning CA, Kloess PM, Diaz D, et al: Intraoperative mitomycin C in primary pterygium excision: A prospective randomized trial. Ophthalmology 1997;104:844-848.
2. Anduze AL: Pterygium surgery with mitomycin C: Ten year results. Ophthalmic Surg Lasers 2000;32:341-345.
3. Ivekovic R, Mandie Z, Saric D, Sonicki Z: Comparative study of pterygium surgery. Ophthalmologica 2001;215:394-397.
4. Lam DSC, Wong AKK, Fan DSP, et al: Intraoperative mitomycin C to prevent recurrence of pterygium after excision. Opthalmology 1998;105:901-905.
5. Kunitomo N, Mori S: Studies on pterygium: Report IV. A treatment of pterygium by mitomycin C. Acta Soc Ophthalmol Jpn 1963;67:601-607.
6. Caliskan S, Orhan M, Irkec M: Intraoperative and postoperative use of mitomycin C in treatment of primary pterygium. Ophthalmic Surg Lasers 1996;27:600-604.
7. Helal M, Messiha N, Amayem A, et al: Intraoperative mitomycin V versus postoperative topical mitomycin C drops for the treatment of pterygium. Ophthalmic Surg Lasers 1996;27:674-678.
8. Saika S, Ooshima A, Yamanaka O, Kimura M, Okada Y, Tonoe O, Tanaka S, Ohnishi Y: In vitro effects of doxorubicin and mitomycin C on human tenon's capsule fibroblasts. Ophthalmic Res 1997;29:91-102.
9. Nguyen LT, Mcloon LK, Wirtschafter JD: Doxorubicin chemomyectomy is enhanced when performed two days following bupivacaine injections: The effect coincides with the peak of muscle satellite cell division. IOVS 1998;39:203-206.
10. Mcloon LK, Wirtschafter JD: Direct injection of liposome-encapsulated doxorubicin optimizes chemomyectomy in rabbit eyelid. IOVS 1999;40:2561-2567.
11. Gomez-Ramirez AM, Villegas-Perez MP, de Imperial JM, Salvador-Silva M, Vidal-Sanz M: Effects of intramuscular injection of botulinum toxin and doxorubicin on the survival of abducens motorneurons. IOVS 1999;40:414-424.
12. Wirtschafter JD: Clinical doxorubicin chemomyectomy. An experimental treatment for benign essential blepharospasm and hemifacial spasm. Ophthalmology 1991;98:357-366.
13. Mcloon LK, Luo XX, Wirtschafter JD: Acute morphologic changes in orbicularis oculi muscle after doxorubicin injection into the eyelid. Muscle Nerve 1993;16:737-743.
14. Wirtschafter JD, Mcloon LK: Long term efficacy of local doxorubicin chemomyectomy in patients with blepharospasm and hemifacial spasm. Ophthalmology 1998;105:342-346.
15. Ombrain A: The surgical treatment of pterygium. Br J Ophthalmol 1948;32:65-71.
16. Cheng H-C Tseng S-H, Kao P-L, Chen FK: Low dose intraoperative Mitomycin C as chemoadjuvant for pterygium surgery. Cornea 2001;20:24-29.
17. Heiligenhaus A, Akova Y, Lung E, et al: Pterygium excision with intraoperative administration of low dosage mitomycin C. Ophthalmologe 1995;92:458-462.
18. Cardillo JA, Alves MR, Ambroso LE, et al: Single intraoperative application versus post-operative mitomycin C eye drops in pterygium surgery. Ophthalmology 1995;102:1949-1952.
19. Cano-Parra J, Diaz LM, Maldonado MJ, et al: Prospective trial of intraoperative mitomycin C in the treatment of primary pterygium. Br J Ophthalmol 1995;79:439-441.
20. Frucht-Pery J, Siganos CS, Ilsar M: Intraoperative application of topical mitomycin C for pterygium surgery. Ophthalmology 1996;103:674-677.
21. Rubinfeld RS, Stein RM: Topical mitomycin C for pterygia: Is a single application appropriate? Ophthalmic Surg Lasers 1997;28:662-669.
22. Panda A, Das GK, Tuli SW, et al: Randomized trial of intraoperative mitomycin C in surgery for pterygium. Am J Ophthalmol 1998;125:59-63.
23. Dougherty PJ, Hardten DR, Lindstrom RL: Corneo-scleral melt after pterygium surgery using a single intraoperative application of MMC. Cornea 1996;15:537-540.
24. Tsai Y-Y, Lin J-M, Shy J-D: Acute scleral thinning after pterygium excision with intraoperative MMC. Cornea 2002;21:227-229.
25. Stephen GW, Anthony PA: Pterygium; in Tasman W, Jaeger EA (eds): Duane's Clinical Ophthalmology. Philadelphia, Lippincott Williams and Wilkins, 1998, chapt 35, vol 6, pp 8-9.
26. Doroshow JH: Anthracyclines and anthracenediones: in Chabner BA, Longo DL (eds): Cancer Chemotherapy and Biotherapy. Principles and Practice, ed 3. Philadelphia, Lippincott Williams and Wilkins, 2001, chapt 18, p 510.
27. Beard SE, Capaldi SR, Gee P: Stress responses to DNA damaging agents in the human colon carcinoma cell line, RKO. Mutat Res 1996;371:1-13.
28. Hirst LW: The treatment of pterygium. Surv Ophthalmol 2003;48:145-180.